
A Medicine Company | Eli Lilly and Company
Lilly is a medicine company that puts health above all. Learn about our medicines, view condition support, find care, and much more.
Eli Lilly and Company - Wikipedia
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries.
Lilly to Acquire Adverum Biotechnologies
2 days ago · Lilly to Acquire Adverum Biotechnologies Eli Lilly and Company (NYSE: LLY ) and Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage company pioneering the use …
Eli Lilly bets on eye care with buyout of gene therapy developer ...
1 day ago · Eli Lilly said on Friday it would acquire gene therapy developer Adverum Biotechnologies in a deal valued at up to $261.7 million, aiming to strengthen its pipeline with …
Lilly to Buy Eye Gene Therapy Company Adverum Biotechnologies
1 day ago · Eli Lilly & Co. agreed to buy Adverum Biotechnologies Inc., a company working to treat blindness, in a deal that ultimately could be worth $261.7 million as it continues a push …
Find Your Career with Eli Lilly | Lilly Careers
Find your place at Lilly. For more than a century, we have united caring with discovery to make life better.
Adverum, hammered by gene therapy downturn, sells to Lilly in …
2 days ago · Lilly’s upfront offer for Adverum, the developer of a gene therapy for age-related macular degeneration, is less than the company’s previous closing share price.
Lilly Dives Deeper Into Gene Therapy With up to $262M Adverum …
1 day ago · The cornerstone of the deal is Ixo-vec, an intravitreal gene therapy currently in Phase III development for wet age-related macular degeneration. Eli Lilly made another foray into …
About Us | Eli Lilly and Company
Key facts about Lilly Learn more about Lilly and our global presence at a glance.
Lilly Up 10% in a Month: Should You Buy, Sell or Hold the Stock?
3 days ago · Lilly stock climbs nearly 10% in a month amid a broader recovery in the drug and biotech sector.